SLS SELLAS Life Sciences Group, Inc.
Fundamentals / CIK 0001390478 / USDSELLAS Life Sciences Group, Inc. reported $141.1M in total assets and a net loss of $35.76M through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open SLS in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$39.45M Operating profit
-
Net Income FY 2025-$35.76M GAAP bottom line
-
Diluted EPS FY 2025-$0.18 Split-adjusted
-
Free Cash Flow FY 2025-- Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$134.7M Total debt: $599K
Annual revenue and net income
10 fiscal years (2016 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -- | -- | $0 | $1.00M | $7.60M | $1.90M | $0 | -- | -- | -- |
| Cost of Revenue | $0 | $0 | $0 | $100K | $200K | $0 | -- | -- | -- | -- |
| Gross Profit | -- | -- | $0 | $900K | $7.40M | $1.90M | -- | -- | -- | -- |
| Research & Development | $16.02M | $19.10M | $24.01M | $20.27M | $15.67M | $9.28M | $7.29M | $8.77M | $6.07M | $11.39M |
| Selling, General & Admin | $12.25M | $12.42M | $13.86M | $12.58M | $11.32M | $9.60M | $9.92M | $12.77M | $15.09M | $4.59M |
| Total Operating Expenses | -- | -- | -- | -- | -- | -- | -- | -- | -- | $31.87M |
| Operating Income | -$28.27M | -$31.51M | -$37.87M | -$41.95M | -$25.29M | -$16.98M | -$20.04M | $0 | -$23.04M | -$15.99M |
| EBITDA | -- | -- | -- | -- | -- | -- | -- | -- | -- | -$15.98M |
| Income Before Tax | -$26.86M | -$30.88M | -$37.34M | -$41.30M | -$20.94M | -$16.77M | -$19.37M | -$29.05M | -$23.50M | -$17.68M |
| Income Tax Expense | $0 | $0 | $0 | $0 | -$237K | -$17K | -$81K | -$1.38M | $253K | $1.0K |
| Net Income | -$26.86M | -$30.88M | -$37.34M | -$41.30M | -$20.70M | -$16.76M | -$19.29M | -$27.67M | -$23.75M | -$17.68M |
| Basic EPS | -$0.25 | -$0.50 | -$1.34 | -$2.13 | -$1.34 | -$2.11 | -$10.92 | -$157.72 | -$522.00 | -$933.00 |
| Diluted EPS | -$0.25 | -$0.50 | -$1.34 | -$2.13 | -$1.34 | -$2.11 | -$10.92 | -$157.72 | -$522.00 | -$933.00 |
| Basic Shares Outstanding | 109.1M | 61.2M | 27.8M | 19.4M | 15.5M | 8.0M | 2.6M | 261.5K | 46.8K | 18.9K |
| Diluted Shares Outstanding | 109.1M | 61.2M | 27.8M | 19.4M | 15.5M | 8.0M | 2.6M | 261.5K | 46.8K | 18.9K |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Research & Development | $7.03M | $6.27M | $5.13M | $4.73M | $4.22M | $3.87M | $3.21M | $4.44M |
| Selling, General & Admin | -- | -- | -- | $3.52M | $2.87M | $3.00M | $2.86M | $2.48M |
| Operating Income | -$11.31M | -$10.63M | -$9.25M | -$8.26M | -$7.08M | -$6.87M | -$6.06M | -$6.92M |
| Net Income | -$10.09M | -$9.61M | -$8.41M | -$7.66M | -$6.79M | -$6.60M | -$5.81M | -$6.74M |
| Basic EPS | -$0.05 | -$0.05 | -$0.05 | -- | -$0.06 | -$0.07 | -$0.07 | -- |
| Diluted EPS | -$0.05 | -$0.05 | -$0.05 | -- | -$0.06 | -$0.07 | -$0.07 | -- |
| Basic Shares Outstanding | 202.4M | 189.2M | 172.5M | -- | 108.4M | 98.6M | 87.8M | -- |
| Diluted Shares Outstanding | 202.4M | 189.2M | 172.5M | -- | 108.4M | 98.6M | 87.8M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $71.79M | $13.89M | $2.53M | $17.12M | $21.36M | $35.30M | $7.28M | $5.34M | $2.32M | $5.96M |
| Cash & Short-Term Investments | $71.79M | $13.89M | $2.53M | $17.12M | $21.36M | $35.30M | $7.28M | $5.34M | $2.32M | $5.96M |
| Accounts Receivable, Net | -- | -- | -- | -- | $0 | -- | -- | -- | -- | -- |
| Total Current Assets | $75.21M | $16.33M | $3.17M | $17.76M | $23.04M | $36.92M | $8.24M | $5.84M | $13.09M | $6.38M |
| Property, Plant & Equipment, Net | -- | -- | -- | -- | -- | -- | -- | -- | -- | $199K |
| Goodwill | $1.91M | $1.91M | $1.91M | $1.91M | $1.91M | $1.91M | $1.91M | $1.91M | $1.91M | $5.90M |
| Total Non-Current Assets | $3.13M | $3.10M | $3.05M | $3.19M | $3.23M | $9.12M | $8.37M | $11.08M | $20.44M | $41K |
| Total Assets | $78.34M | $19.43M | $6.22M | $20.94M | $26.27M | $46.05M | $16.61M | $16.91M | $33.53M | $6.42M |
| Accounts Payable | $2.95M | $3.50M | $5.64M | $3.36M | $2.14M | $4.66M | $3.90M | $3.75M | $11.69M | $840K |
| Short-Term Debt | -- | -- | -- | -- | -- | -- | -- | $0 | $8.38M | $16.40M |
| Deferred Revenue (Current) | -- | -- | -- | -- | $0 | $5.60M | $0 | -- | -- | -- |
| Total Current Liabilities | $7.02M | $9.51M | $13.73M | $15.52M | $4.98M | $12.34M | $5.29M | $5.97M | $24.57M | $5.76M |
| Long-Term Debt | -- | -- | -- | -- | -- | -- | -- | $0 | $2.61M | -- |
| Total Non-Current Liabilities | $457K | $457K | $460K | $577K | $946K | $5.75M | $5.23M | $5.70M | $6.89M | $5.66M |
| Total Liabilities | $7.47M | $9.97M | $14.20M | $16.09M | $5.93M | $18.09M | $10.52M | $11.67M | $31.46M | $11.42M |
| Total Debt (incl. Leases) | $1.00M | $1.00M | $906K | $945K | $808K | $991K | $217K | $0 | $10.99M | $16.40M |
| Common Stock | $15K | $7.0K | $3.0K | $2.0K | $2.0K | $1.0K | $1.0K | $1.0K | $1.0K | $2.0K |
| Retained Earnings | -$275.0M | -$248.1M | -$217.2M | -$179.9M | -$138.6M | -$117.9M | -$101.1M | -$81.86M | -$54.19M | -$30.43M |
| Total Stockholders' Equity | $70.87M | $9.46M | -$7.98M | $4.85M | $20.35M | $27.96M | $6.09M | $5.25M | $2.07M | -$5.00M |
| Total Equity | $70.87M | $9.46M | -$7.98M | $4.85M | $20.35M | $27.96M | $6.09M | $5.25M | $2.07M | -$5.00M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $134.7M | $138.3M | $107.1M | $71.79M | $44.32M | $25.30M | $28.40M | $13.89M |
| Cash & Short-Term Investments | $134.7M | $138.3M | $107.1M | $71.79M | $44.32M | $25.30M | $28.40M | $13.89M |
| Total Current Assets | $138.6M | $142.5M | $111.2M | $75.21M | $49.05M | $29.45M | $31.97M | $16.33M |
| Goodwill | $1.91M | $1.91M | $1.91M | $1.91M | $1.91M | $1.91M | $1.91M | $1.91M |
| Total Non-Current Assets | $2.52M | $2.88M | $3.01M | $3.13M | $2.50M | $2.86M | $2.98M | $3.10M |
| Total Assets | $141.1M | $145.4M | $114.2M | $78.34M | $51.55M | $32.30M | $34.96M | $19.43M |
| Accounts Payable | $2.09M | $3.09M | $3.63M | $2.95M | $2.31M | $3.34M | $3.76M | $3.50M |
| Total Current Liabilities | $9.29M | $7.57M | $6.46M | $7.02M | $5.92M | $6.00M | $6.89M | $9.51M |
| Total Non-Current Liabilities | $0 | $157K | $309K | $457K | $0 | $157K | $309K | $457K |
| Total Liabilities | $9.29M | $7.73M | $6.76M | $7.47M | $5.92M | $6.16M | $7.20M | $9.97M |
| Total Debt (incl. Leases) | $599K | $737K | $871K | $1.00M | $599K | $737K | $870K | $1.00M |
| Common Stock | $20K | $20K | $18K | $15K | $12K | $10K | $9.0K | $7.0K |
| Retained Earnings | -$303.1M | -$293.0M | -$283.4M | -$275.0M | -$267.3M | -$260.5M | -$253.9M | -$248.1M |
| Total Stockholders' Equity | $131.8M | $137.7M | $107.4M | $70.87M | $45.63M | $26.15M | $27.76M | $9.46M |
| Total Equity | $131.8M | $137.7M | $107.4M | $70.87M | $45.63M | $26.15M | $27.76M | $9.46M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$26.86M | -$30.88M | -$37.34M | -$41.30M | -$20.70M | -$16.76M | -$19.29M | -$27.67M | -$23.75M | -$17.68M |
| Depreciation & Amortization | -- | -- | -- | -- | -- | -- | -- | -- | -- | $3.0K |
| Stock-Based Compensation | $1.96M | $1.56M | $2.09M | $1.73M | $1.01M | $578K | $573K | $395K | $3.17M | $354K |
| Change in Payables | -$535K | -$2.14M | $2.30M | $1.21M | -$2.51M | -$836K | $12K | -$7.94M | $8.37M | -$757K |
| Operating Cash Flow | -$28.39M | -$35.40M | -$31.41M | -$23.81M | -$26.02M | -$10.42M | -$17.64M | -$30.42M | -$10.99M | -$11.85M |
| Capital Expenditure | -- | -- | -- | -- | -- | -- | -- | -- | -- | -$6.0K |
| Free Cash Flow | -- | -- | -- | -- | -- | -- | -- | -- | -- | -$11.86M |
| Investing Cash Flow | -- | $0 | -$5.50M | -$4.50M | $0 | -- | -- | $0 | $12.16M | -$85K |
| Common Stock Issued | -- | $0 | $289K | $1.05M | $9.01M | $29.60M | $15.97M | $21.56M | $6.01M | $33.53M |
| Dividends Paid | -- | -- | -- | -- | -- | -- | $0 | -$487K | $0 | -- |
| Financing Cash Flow | $86.30M | $46.76M | $22.32M | $24.08M | $12.07M | $38.44M | $19.57M | $23.12M | $5.53M | $16.50M |
| Net Change in Cash | $57.91M | $11.36M | -$14.60M | -$4.23M | -$13.95M | $28.02M | $1.93M | -$7.30M | $6.70M | $4.57M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$10.09M | -$9.61M | -$8.41M | -$7.66M | -$6.79M | -$6.60M | -$5.81M | -$6.74M |
| Stock-Based Compensation | $1.93M | $1.01M | $798K | $447K | $503K | $501K | $505K | $373K |
| Change in Payables | -$997K | -$547K | $685K | $660K | -$1.03M | -$441K | $277K | -$1.12M |
| Operating Cash Flow | -$5.94M | -$7.59M | -$8.85M | -$4.92M | -$7.07M | -$7.33M | -$9.07M | -$7.15M |
| Common Stock Issued | -- | -- | -- | -- | -- | -- | -- | $0 |
| Financing Cash Flow | $2.31M | $38.83M | $44.15M | $32.39M | $26.09M | $4.23M | $23.58M | $8.0K |
| Net Change in Cash | -$3.63M | $31.25M | $35.30M | $27.47M | $19.02M | -$3.10M | $14.51M | -$7.14M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | -- | -- | -- | 90.0% | 97.4% | 100.0% | -- | -- | -- | -- |
| Operating Margin | -- | -- | -- | -4195.0% | -332.8% | -893.8% | -- | -- | -- | -- |
| Net Profit Margin | -- | -- | -- | -4130.1% | -272.4% | -881.9% | -- | -- | -- | -- |
| Return on Equity (ROE) | -37.9% | -326.3% | -- | -851.4% | -101.7% | -59.9% | -316.6% | -527.6% | -1147.5% | -- |
| Return on Assets (ROA) | -34.3% | -158.9% | -600.4% | -197.2% | -78.8% | -36.4% | -116.2% | -163.6% | -70.9% | -275.4% |
| Current Ratio | 10.72x | 1.72x | 0.23x | 1.14x | 4.63x | 2.99x | 1.56x | 0.98x | 0.53x | 1.11x |
| Quick Ratio | 10.23x | 1.46x | 0.18x | 1.10x | 4.29x | 2.86x | 1.38x | 0.89x | 0.09x | 1.04x |
| Debt to Equity | 0.01x | 0.11x | -- | 0.19x | 0.04x | 0.04x | 0.04x | 0.00x | 5.31x | -- |
| Revenue Growth (YoY) | -- | -- | -100.0% | -86.8% | +300.0% | -- | -- | -- | -- | -- |
| Gross Profit Growth (YoY) | -- | -- | -100.0% | -87.8% | +289.5% | -- | -- | -- | -- | -- |
| 5Y Revenue / Share Growth | -- | -- | -- | -- | -- | -- | -100.0% | -- | -- | -- |
| 10Y Revenue / Share Growth | -- | -- | -100.0% | -- | -- | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -27.1% | -23.6% | -27.4% | -37.9% | -56.9% | -100.4% | -97.7% | -326.3% |
| Return on Assets (ROA) | -25.3% | -22.3% | -25.8% | -34.3% | -50.3% | -81.3% | -77.6% | -158.9% |
| Current Ratio | 14.92x | 18.83x | 17.22x | 10.72x | 8.28x | 4.91x | 4.64x | 1.72x |
| Quick Ratio | 14.51x | 18.28x | 16.59x | 10.23x | 7.48x | 4.22x | 4.12x | 1.46x |
| Debt to Equity | 0.00x | 0.01x | 0.01x | 0.01x | 0.01x | 0.03x | 0.03x | 0.11x |